image, Jeannette Jackson-Thompson

MCR-ARC Staff - Jeannette Jackson-Thompson

Jeannette Jackson-Thompson, MSPH, PhD - Director

401 Clark Hall
University of Missouri
Columbia, MO 65211
1-800-392-2829
573-882-7775
jacksonthompsonj@health.missouri.edu
Curriculum Vitae


In addition to her role as Director of the Missouri Cancer Registry and Research Center (MCR-ARC), Dr. Jackson-Thompson is a Research Associate Professor in the University of Missouri-Columbia (MU) School of Medicine’s Department of Health Management and Informatics and is core faculty in the University of Missouri Informatics Institute. From 1996 until 2002, she was Chief, Office of Surveillance, Research and Evaluation, Missouri Department of Health and Senior Services and was involved in drafting the plan that led to outsourcing surveillance operations (MCR and the Behavioral Risk Factor Surveillance System) to MU in 1999. Dr. Jackson-Thompson currently serves as the Voting Delegate to the North American Association of Central Cancer Registries (NAACCR) and the International Association of Cancer Registries (IARC). She chairs the NAACCR Uniform Data Standards Committee and serves on a variety of NAACCR committees and work groups (e.g., Cancer Registration Steering Committee, Change Management Work Group, Data Use and Research Committee, Data Evaluation and Certification Committee). Dr. Jackson-Thompson serves on the Centers for Disease Control and Prevention National Program of Cancer Registries AERRO (Advancing E-cancer Reporting and Registry Operations) Work Group. She is also a member of the American Public Health Association and its Health Informatics/Information Technology and epidemiology sections; National Association of Cancer Registrars; Missouri State Cancer Registrars Association; and the Missouri Cancer Consortium where she chairs the Data and Surveillance Subcommittee. Current grant/contract support includes a central cancer registry operations contract with the Missouri Department of Health and Senior Services; two ARRA-funded projects to enhance cancer registry data for comparative effectiveness research; and an osteosarcoma surveillance study.

 

Untitled Document